Morgan Stanley Direct Lending's portfolio is growing and diversifying with an increase in investee companies. Click here to ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Shares of Morgan Stanley MS shed 0.02% to $125.72 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 5,881.63 and Dow ...

In the most recent trading session, Morgan Stanley (MS) closed at $125.72, indicating a -0.02% shift from the previous trading day.

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Investment bank Morgan Stanley on Friday issued a bullish report on artificial intelligence chipmakers, calling Nvidia stock ...

Morgan Stanley analyst Jeffrey Adelson raised the firm’s price target on SoFi Technologies (SOFI) to $13 from $7.50 and keeps an Underweight ...

Despite Zinka Logistics strengths, Morgan Stanley is cautious about the stock’s valuation following its recent 105 percent run-up.

Shares of Morgan Stanley MS slipped 0.80% to $125.75 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow ...